Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nipro ( (JP:8086) ) just unveiled an update.
Nipro Corporation has reported a significant increase in non-operating expenses due to a foreign exchange loss of 5.381 billion yen for the fiscal year ending March 2025. This loss, primarily caused by the rapid appreciation of the yen affecting USD-denominated receivables, has been reflected in their consolidated financial results, indicating potential challenges in their financial performance and market positioning.
More about Nipro
Nipro Corporation operates in the healthcare industry, focusing on the production and distribution of medical devices, pharmaceutical products, and glass products. The company primarily serves markets that require advanced healthcare solutions and technologies.
YTD Price Performance: -12.84%
Average Trading Volume: 478,359
Technical Sentiment Signal: Hold
Current Market Cap: Yen209.7B
Learn more about 8086 stock on TipRanks’ Stock Analysis page.